Wright Investors Service Lowered By $509,574 Its Abbvie (ABBV) Holding; Two Sigma Securities Has Trimmed By $530,400 Its Bb&T (Put) (BBT) Position

July 12, 2018 - By Mary Bollinger

AbbVie Inc. (NYSE:ABBV) Logo

Wright Investors Service Inc decreased Abbvie Inc (ABBV) stake by 9.92% reported in 2018Q1 SEC filing. Wright Investors Service Inc sold 5,421 shares as Abbvie Inc (ABBV)’s stock declined 16.83%. The Wright Investors Service Inc holds 49,232 shares with $4.66M value, down from 54,653 last quarter. Abbvie Inc now has $143.78B valuation. The stock decreased 3.93% or $3.88 during the last trading session, reaching $94.96. About 6.23 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 52.41% since July 12, 2017 and is uptrending. It has outperformed by 39.84% the S&P500. Some Historical ABBV News: 01/05/2018 – AbbVie: Tender Offer and Withdrawal Rights Will Expire at Midnight ET May 29, 2018; 09/04/2018 – KEYTRUDA® (pembrolizumab) Monotherapy Met Primary Endpoint in Phase 3 KEYNOTE-042 Study, Significantly Improving OS as First-Line Therapy in Locally Advanced or Metastatic NSCLC Patients Expressing PD-L1 in at Least 1 Percent of Tumor; 23/04/2018 – EUROPEAN MEDICINES AGENCY VALIDATES TYPE Il VARIATION FOR MERCK’S KEYTRUDA® (PEMBROLIZUMAB) IN COMBINATION WITH PEMETREXED (ALIMTA®) AND PLATINUM CHEMOTHERAPY AS FIRST-LINE THERAPY IN METASTATIC; 25/04/2018 – ABBVIE INC – SAFETY PROFILE OF UPADACITINIB WAS CONSISTENT WITH PREVIOUSLY REPORTED RESULTS, WITH NO NEW SAFETY SIGNALS DETECTED; 22/03/2018 – AbbVie in $25bn wipeout after cancer drug results; 08/05/2018 – AbbVie at Deutsche Bank Health Care Conference Tomorrow; 25/05/2018 – IMFINZI® (Durvalumab) Significantly Improves Overall Survival in the Phase lll Pacific Trial for Unresectable Stage lll Non-Small Cell Lung Cancer; 22/03/2018 – AbbVie: Safety Data in the TRINITY Study Were Consistent With Previously Reported Studies of Rova-T; 13/03/2018 – FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for; 24/05/2018 – FMI,MRK IN COLLABORATION PACT FOR KEYTRUDA COMPANION DIAGNOSTIC

Two Sigma Securities Llc decreased Bb&T Corp (Put) (BBT) stake by 52.85% reported in 2018Q1 SEC filing. Two Sigma Securities Llc sold 10,200 shares as Bb&T Corp (Put) (BBT)’s stock declined 1.68%. The Two Sigma Securities Llc holds 9,100 shares with $474,000 value, down from 19,300 last quarter. Bb&T Corp (Put) now has $40.45 billion valuation. The stock decreased 0.86% or $0.45 during the last trading session, reaching $51.87. About 2.75M shares traded. BB&T Corporation (NYSE:BBT) has risen 28.68% since July 12, 2017 and is uptrending. It has outperformed by 16.11% the S&P500. Some Historical BBT News: 27/03/2018 – BB&T CORP BBT.N : WELLS FARGO RAISES TARGET PRICE TO $63 FROM $55; 22/04/2018 – DJ BB&T Corporation, Inst Holders, 1Q 2018 (BBT); 19/04/2018 – BB&T 1Q Effective Tax Rate 19%; 29/05/2018 – BB&T Presenting at Deutsche Bank Conference Tomorrow; 19/04/2018 – BB&T CORP – SEES FY 2018 REV UP 2 PCT – 4 PCT VS 2017; 23/05/2018 – BB&T Presenting at Conference May 30; 29/05/2018 – BB&T Closes Below 50-Day Moving Average: Technicals; 15/03/2018 – BB&T CORP – CHRISTIAN CORTS HAS BEEN NAMED PRESIDENT FOR ITS TENNESSEE REGION; 19/04/2018 – BB&T CORP – SEES FY 2018 AVERAGE TOTAL LOANS UP 1 PCT TO 3 PCT VS 2017; 27/03/2018 – BB&T CORP BBT.N : WELLS FARGO RAISES TO OUTPERFORM

Since February 19, 2018, it had 2 buys, and 10 sales for $26.21 million activity. SALEKI-GERHARDT AZITA had sold 1,337 shares worth $157,458 on Wednesday, February 28. ALBAN CARLOS sold $9.57 million worth of stock. RICHMOND TIMOTHY J. sold $2.15M worth of stock or 18,129 shares. 1,013 shares valued at $99,909 were bought by RAPP EDWARD J on Wednesday, June 20. Schumacher Laura J sold 25,000 shares worth $2.95M. $311,684 worth of AbbVie Inc. (NYSE:ABBV) shares were sold by SEVERINO MICHAEL. $119,351 worth of stock was sold by Michael Robert A. on Monday, February 19.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 earnings per share, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $2.98B for 12.05 P/E if the $1.97 EPS becomes a reality. After $1.87 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “AbbVie’s Imbruvica flunks late-stage DLBCL study; shares down 2% premarket” on July 11, 2018, also Streetinsider.com with their article: “AbbVie (ABBV) Reports Submission of Supplemental New Drug Application to FDA for Venetoclax” published on July 12, 2018, Fool.com published: “Better Buy: Eli Lilly and Company vs. AbbVie” on July 09, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie: The Right Combination Of Dividends And Growth” published on July 05, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie On A Roll, Buy AbbVie” with publication date: June 28, 2018.

Among 14 analysts covering AbbVie (NYSE:ABBV), 5 have Buy rating, 2 Sell and 7 Hold. Therefore 36% are positive. AbbVie had 27 analyst reports since January 16, 2018 according to SRatingsIntel. Piper Jaffray downgraded it to “Hold” rating and $10500 target in Friday, June 1 report. The firm has “Hold” rating given on Monday, January 29 by Leerink Swann. The firm has “Equal-Weight” rating given on Monday, April 30 by Morgan Stanley. The rating was maintained by Credit Suisse with “Neutral” on Friday, April 27. The firm has “Buy” rating given on Monday, February 26 by Jefferies. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Cowen & Co on Friday, January 26. On Wednesday, May 23 the stock rating was maintained by BMO Capital Markets with “Underperform”. On Tuesday, January 30 the stock rating was downgraded by BMO Capital Markets to “Underperform”. The stock has “Buy” rating by Argus Research on Friday, February 2. The firm earned “Buy” rating on Friday, April 13 by Jefferies.

Wright Investors Service Inc increased Marathon Oil Corp (NYSE:MRO) stake by 48,452 shares to 96,881 valued at $1.56M in 2018Q1. It also upped Aflac Inc (NYSE:AFL) stake by 10,921 shares and now owns 21,741 shares. Gentex Corp (NASDAQ:GNTX) was raised too.

Investors sentiment decreased to 0.7 in Q1 2018. Its down 0.10, from 0.8 in 2017Q4. It dropped, as 61 investors sold ABBV shares while 737 reduced holdings. 127 funds opened positions while 428 raised stakes. 1.06 billion shares or 0.67% less from 1.06 billion shares in 2017Q4 were reported. Chemung Canal Trust Co holds 0.37% in AbbVie Inc. (NYSE:ABBV) or 16,205 shares. Oakworth Capital Inc has invested 0.21% in AbbVie Inc. (NYSE:ABBV). Beck Management Lc owns 41,679 shares. Pitcairn holds 0.24% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 24,028 shares. 118,249 were reported by Bainco Investors. Yorktown And Research has 0.5% invested in AbbVie Inc. (NYSE:ABBV) for 17,800 shares. Patten invested 0.11% in AbbVie Inc. (NYSE:ABBV). Fayerweather Charles reported 6,479 shares. Massmutual Communications Fsb Adv has 0% invested in AbbVie Inc. (NYSE:ABBV). Mutual Of Omaha Retail Bank Wealth reported 126,623 shares. Wilbanks Smith Thomas Asset Management Lc stated it has 0.18% in AbbVie Inc. (NYSE:ABBV). Benedict Advisors invested in 2,394 shares or 0.11% of the stock. Financial Advisory invested in 3,118 shares. The New York-based Beech Hill Advsr has invested 2.77% in AbbVie Inc. (NYSE:ABBV). Qs Invsts Ltd Limited Liability Company accumulated 298,216 shares.

Analysts await BB&T Corporation (NYSE:BBT) to report earnings on July, 19 before the open. They expect $1.01 EPS, up 29.49% or $0.23 from last year’s $0.78 per share. BBT’s profit will be $787.55 million for 12.84 P/E if the $1.01 EPS becomes a reality. After $0.97 actual EPS reported by BB&T Corporation for the previous quarter, Wall Street now forecasts 4.12% EPS growth.

More notable recent BB&T Corporation (NYSE:BBT) news were published by: Seekingalpha.com which released: “Banks report dividend boost, buybacks on no objection to its capital plan” on June 28, 2018, also Bizjournals.com with their article: “FDIC, state banking commissioner end BB&T consent order” published on July 01, 2018, Seekingalpha.com published: “Regional Banks BB&T, M&T, PNC, SunTrust, US Bancorp Holding Key Levels Pre-Earnings” on July 08, 2018. More interesting news about BB&T Corporation (NYSE:BBT) were released by: Bizjournals.com and their article: “BB&T gets naming rights to A&T stadium” published on June 15, 2018 as well as Bizjournals.com‘s news article titled: “How much does CEO Kelly King believe BB&T will change when he is gone?” with publication date: June 21, 2018.

Two Sigma Securities Llc increased Avis Budget Group (Put) (NASDAQ:CAR) stake by 11,000 shares to 39,700 valued at $1.86M in 2018Q1. It also upped Deutsche Bank Ag (NYSE:DB) stake by 140,025 shares and now owns 152,848 shares. Steel Dynamics Inc (Put) (NASDAQ:STLD) was raised too.

Among 17 analysts covering BB&T Corp (NYSE:BBT), 9 have Buy rating, 0 Sell and 8 Hold. Therefore 53% are positive. BB&T Corp had 26 analyst reports since January 18, 2018 according to SRatingsIntel. BMO Capital Markets upgraded BB&T Corporation (NYSE:BBT) rating on Thursday, February 8. BMO Capital Markets has “Buy” rating and $64.0 target. Keefe Bruyette & Woods maintained BB&T Corporation (NYSE:BBT) on Monday, February 26 with “Hold” rating. On Thursday, April 19 the stock rating was maintained by Sandler O’Neill with “Hold”. The rating was maintained by SunTrust with “Buy” on Thursday, January 18. B. Riley & Co upgraded the shares of BBT in report on Tuesday, March 27 to “Buy” rating. The stock has “Hold” rating by Sandler O’Neill on Thursday, January 18. The firm earned “Hold” rating on Thursday, April 19 by Jefferies. The rating was upgraded by Wells Fargo on Tuesday, March 27 to “Outperform”. On Tuesday, March 27 the stock rating was upgraded by FBR Capital to “Buy”. Stephens maintained it with “Buy” rating and $5900 target in Monday, April 23 report.

Since January 19, 2018, it had 0 insider purchases, and 17 insider sales for $25.39 million activity. $3.28 million worth of BB&T Corporation (NYSE:BBT) was sold by KING KELLY S on Friday, January 19. Another trade for 2,500 shares valued at $130,852 was sold by Boyer K. David Jr.. Goodrich Donna C also sold $2.41M worth of BB&T Corporation (NYSE:BBT) shares. 16,279 BB&T Corporation (NYSE:BBT) shares with value of $882,345 were sold by Yates William Rufus. Powell Cynthia B had sold 2,817 shares worth $151,504. Another trade for 68,402 shares valued at $3.66 million was made by DUCK BARBARA F on Wednesday, April 25. The insider Starnes Clarke R III sold 22,629 shares worth $1.25M.

Investors sentiment decreased to 1.12 in Q1 2018. Its down 0.03, from 1.15 in 2017Q4. It worsened, as 36 investors sold BBT shares while 301 reduced holdings. 110 funds opened positions while 268 raised stakes. 481.29 million shares or 0.34% more from 479.66 million shares in 2017Q4 were reported. Mcf Advisors Limited Liability Corp has 68,201 shares for 0.7% of their portfolio. Zacks Investment Mngmt, Illinois-based fund reported 721,612 shares. 905 are owned by Plante Moran Advisors Ltd Liability Corporation. Raymond James Fincl Svcs Advsrs has 0.1% invested in BB&T Corporation (NYSE:BBT). Sterling Cap Mgmt Limited Liability Corp owns 9,974 shares. Philadelphia Tru Co reported 244,495 shares or 1.06% of all its holdings. California-based Lpl Financial Ltd Liability Company has invested 0.03% in BB&T Corporation (NYSE:BBT). Richard C Young Co Ltd has invested 2.04% in BB&T Corporation (NYSE:BBT). Thompson Siegel & Walmsley Ltd holds 0.01% or 11,884 shares. Mckinley Carter Wealth Services invested in 0.02% or 960 shares. Eagle Ridge Investment Mgmt holds 0.04% or 5,227 shares. Moreover, Quadrant Cap Ltd Llc has 1.51% invested in BB&T Corporation (NYSE:BBT). Art Ltd stated it has 44,100 shares or 0.09% of all its holdings. Stratos Wealth Ltd holds 0.14% or 65,806 shares in its portfolio. Fort Washington Oh reported 0.05% of its portfolio in BB&T Corporation (NYSE:BBT).

BB&T Corporation (NYSE:BBT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts